XIAP and colorectal carcinoma: We report for the first time the antitumor activity of MK-0646 in IGF-1R-dependent CRC cells and demonstrate that inhibition of IGF-1R leads to control of aberrant cell survival signaling through the downregulation of XIAP and induction of cell death.